Impel Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Impel Pharmaceuticals's balance sheet done over the years? Its assets were worth $88,550,000 last year, which is less than in the previous period. 150% of Impel Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $132,707,000, which means an increase by 192% compared compared to last year.
Debt to Assets
| 2019 | 42265000 | 133.96M | 316.97% |
|---|---|---|---|
| 2020 | 12059000 | 145.55M | 1207.06% |
| 2021 | 97912000 | 45.40M | 46.37% |
| 2022 | 88550000 | 132.70M | 149.87% |
IMPL Balance Sheet (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | 60.65M | 88.21M | 7.09M | 37.00M |
Short term investments | 0 | 0 | 0 | 0 |
Net receivables | 7.44M | 1.35M | 229K | 201K |
Inventory | 8.42M | 2.82M | -229K | -201K |
Other current assets | 3.28M | 2.18M | 1.07M | 2.52M |
Total current assets | 79.80M | 94.57M | 8.17M | 39.52M |
Non-current assets: | ||||
Property, Plant and Equipment | 6.99M | 3.14M | 3.7M | 2.74M |
Goodwill | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 |
Other non-current assets | 1.74M | 187K | 187K | -2.74M |
Total non-current assets | 8.74M | 3.33M | 3.88M | 2.74M |
Total assets | 88.55M | 97.91M | 12.05M | 42.26M |
Liabilities | ||||
| Current liabilities: | ||||
Accounts payable | ||||
Deferred revenue | 0 | 0 | 3.17M | 0 |
Short term debt | 1.54M | 0 | 417K | 0 |
Total current liabilities | 22.16M | 15.95M | 10.52M | 8.32M |
| Non-current liabilities: | ||||
Long term debt | 49.64M | 29.45M | 7.99M | 0 |
Deferred tax | 0 | 0 | 0 | 0 |
Other non-current liabilities | 60.89M | -29.45M | 127.03M | 0 |
Total non-current liabilities | 110.54M | 29.45M | 135.03M | 125.64M |
Total liabilities | 132.70M | 45.40M | 145.55M | 133.96M |
| Data source | Data source |